1. Home
  2. WIA vs SGHT Comparison

WIA vs SGHT Comparison

Compare WIA & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset Inflation-Linked Income Fund

WIA

Western Asset Inflation-Linked Income Fund

HOLD

Current Price

$8.08

Market Cap

191.5M

Sector

Finance

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$3.77

Market Cap

187.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WIA
SGHT
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.5M
187.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
WIA
SGHT
Price
$8.08
$3.77
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$9.08
AVG Volume (30 Days)
49.5K
389.5K
Earning Date
01-01-0001
03-04-2026
Dividend Yield
12.29%
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
N/A
$11.81
Revenue Next Year
N/A
$10.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.95
$2.03
52 Week High
$8.54
$9.24

Technical Indicators

Market Signals
Indicator
WIA
SGHT
Relative Strength Index (RSI) 40.62 40.10
Support Level N/A $3.29
Resistance Level $8.31 $4.34
Average True Range (ATR) 0.06 0.21
MACD -0.00 0.09
Stochastic Oscillator 45.83 54.29

Price Performance

Historical Comparison
WIA
SGHT

About WIA Western Asset Inflation-Linked Income Fund

Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation. Under normal market conditions and at the time of purchase, the Fund will invest at least 80% of its total managed assets in inflation-linked securities and at least 60% of its total managed assets in U.S. Treasury Inflation Protected Securities (TIPS). The Fund may also invest up to 40% of its total managed assets in non-U.S. dollar investments.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: